Colour theme
Theme
Sign in
Insider · CIK 0001272247

Haughey Thomas

CIK 0001272247 Name as filed on the most recent filing

Filed as Haughey Thomas (11)

94 transaction lines · from 11 filings · filed 2007-10-03 to 2026-06-10 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

94 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.

Transactions filed by this insider
Direction Date Issuer Code Shares Price Value USD Filing
2026-06-08 ANI Pharmaceuticals Inc
ANIP
S, Open-market sale 2,000 disposed 80.88 161,760.00 Form 4, filing 0001272247-26-000004
2025-08-12 ANI Pharmaceuticals Inc
ANIP
S, Open-market sale 19,341 disposed 85.93 1,661,972.13 Form 4, filing 0001272247-25-000005
2021-12-06 ANI Pharmaceuticals Inc
ANIP
P, Open-market purchase 2,500 acquired 39.38 98,450.00 Form 4, filing 0001415889-21-005743
2020-03-04 ANI Pharmaceuticals Inc
ANIP
P, Open-market purchase 3,000 acquired 45.05 135,150.00 Form 4, filing 0001104659-20-029791
2020-03-03 ANI Pharmaceuticals Inc
ANIP
P, Open-market purchase 2,000 acquired 45.18 90,360.00 Form 4, filing 0001104659-20-029791
2019-05-15 ANI Pharmaceuticals Inc
ANIP
P, Open-market purchase 2,500 acquired 69.30 173,240.00 Form 4, filing 0001144204-19-026615
2011-05-10 PAR Pharmaceutical Companies, Inc.
PRX
S, Open-market sale 4,500 disposed 35.65 160,425.00 Form 4, filing 0000878088-11-000048
2011-05-10 PAR Pharmaceutical Companies, Inc.
PRX
S, Open-market sale 2,700 disposed 35.45 95,715.00 Form 4, filing 0000878088-11-000048
2011-05-10 PAR Pharmaceutical Companies, Inc.
PRX
S, Open-market sale 2,658 disposed 35.64 94,731.12 Form 4, filing 0000878088-11-000048
2011-05-10 PAR Pharmaceutical Companies, Inc.
PRX
S, Open-market sale 2,493 disposed 35.46 88,401.78 Form 4, filing 0000878088-11-000048
2011-05-10 PAR Pharmaceutical Companies, Inc.
PRX
S, Open-market sale 2,182 disposed 35.49 77,439.18 Form 4, filing 0000878088-11-000048
2011-05-10 PAR Pharmaceutical Companies, Inc.
PRX
S, Open-market sale 2,100 disposed 35.48 74,508.00 Form 4, filing 0000878088-11-000048
2011-05-10 PAR Pharmaceutical Companies, Inc.
PRX
S, Open-market sale 2,007 disposed 35.47 71,188.29 Form 4, filing 0000878088-11-000048
2011-05-10 PAR Pharmaceutical Companies, Inc.
PRX
S, Open-market sale 1,618 disposed 35.50 57,439.00 Form 4, filing 0000878088-11-000048
2011-05-10 PAR Pharmaceutical Companies, Inc.
PRX
S, Open-market sale 1,100 disposed 35.55 39,105.00 Form 4, filing 0000878088-11-000048
2011-05-10 PAR Pharmaceutical Companies, Inc.
PRX
S, Open-market sale 1,042 disposed 35.66 37,157.72 Form 4, filing 0000878088-11-000048
2011-05-10 PAR Pharmaceutical Companies, Inc.
PRX
S, Open-market sale 800 disposed 35.63 28,504.00 Form 4, filing 0000878088-11-000048
2011-05-10 PAR Pharmaceutical Companies, Inc.
PRX
S, Open-market sale 700 disposed 35.52 24,864.00 Form 4, filing 0000878088-11-000048
2011-05-10 PAR Pharmaceutical Companies, Inc.
PRX
S, Open-market sale 500 disposed 35.69 17,845.00 Form 4, filing 0000878088-11-000048
2011-05-10 PAR Pharmaceutical Companies, Inc.
PRX
S, Open-market sale 500 disposed 35.51 17,755.00 Form 4, filing 0000878088-11-000048
2011-05-10 PAR Pharmaceutical Companies, Inc.
PRX
S, Open-market sale 400 disposed 35.57 14,228.00 Form 4, filing 0000878088-11-000048
2011-05-10 PAR Pharmaceutical Companies, Inc.
PRX
S, Open-market sale 300 disposed 35.61 10,683.00 Form 4, filing 0000878088-11-000048
2011-05-10 PAR Pharmaceutical Companies, Inc.
PRX
S, Open-market sale 200 disposed 35.68 7,136.00 Form 4, filing 0000878088-11-000048
2011-05-10 PAR Pharmaceutical Companies, Inc.
PRX
S, Open-market sale 200 disposed 35.67 7,134.00 Form 4, filing 0000878088-11-000048
2011-05-10 PAR Pharmaceutical Companies, Inc.
PRX
S, Open-market sale 200 disposed 35.58 7,116.00 Form 4, filing 0000878088-11-000048
2011-05-10 PAR Pharmaceutical Companies, Inc.
PRX
S, Open-market sale 200 disposed 35.53 7,106.00 Form 4, filing 0000878088-11-000048
2011-05-10 PAR Pharmaceutical Companies, Inc.
PRX
S, Open-market sale 100 disposed 35.70 3,570.00 Form 4, filing 0000878088-11-000048
2011-05-10 PAR Pharmaceutical Companies, Inc.
PRX
S, Open-market sale 100 disposed 35.62 3,562.00 Form 4, filing 0000878088-11-000048
2011-05-10 PAR Pharmaceutical Companies, Inc.
PRX
S, Open-market sale 100 disposed 35.60 3,560.00 Form 4, filing 0000878088-11-000048
2011-05-10 PAR Pharmaceutical Companies, Inc.
PRX
S, Open-market sale 100 disposed 35.54 3,554.00 Form 4, filing 0000878088-11-000048
2011-05-09 PAR Pharmaceutical Companies, Inc.
PRX
S, Open-market sale 46,961 disposed 35.20 1,653,027.20 Form 4, filing 0000878088-11-000047
2011-05-09 PAR Pharmaceutical Companies, Inc.
PRX
S, Open-market sale 26,313 disposed 34.45 906,482.85 Form 4, filing 0000878088-11-000047
2011-05-09 PAR Pharmaceutical Companies, Inc.
PRX
S, Open-market sale 5,700 disposed 35.19 200,583.00 Form 4, filing 0000878088-11-000047
2011-05-09 PAR Pharmaceutical Companies, Inc.
PRX
S, Open-market sale 4,089 disposed 34.46 140,906.94 Form 4, filing 0000878088-11-000047
2011-05-09 PAR Pharmaceutical Companies, Inc.
PRX
S, Open-market sale 3,155 disposed 35.23 111,150.65 Form 4, filing 0000878088-11-000047
2011-05-09 PAR Pharmaceutical Companies, Inc.
PRX
S, Open-market sale 3,048 disposed 35.22 107,350.56 Form 4, filing 0000878088-11-000047
2011-05-09 PAR Pharmaceutical Companies, Inc.
PRX
S, Open-market sale 2,600 disposed 34.49 89,674.00 Form 4, filing 0000878088-11-000047
2011-05-09 PAR Pharmaceutical Companies, Inc.
PRX
S, Open-market sale 2,587 disposed 35.24 91,165.88 Form 4, filing 0000878088-11-000047
2011-05-09 PAR Pharmaceutical Companies, Inc.
PRX
S, Open-market sale 2,187 disposed 35.15 76,873.05 Form 4, filing 0000878088-11-000047
2011-05-09 PAR Pharmaceutical Companies, Inc.
PRX
S, Open-market sale 1,900 disposed 34.46 65,464.50 Form 4, filing 0000878088-11-000047
2011-05-09 PAR Pharmaceutical Companies, Inc.
PRX
S, Open-market sale 1,600 disposed 35.08 56,128.00 Form 4, filing 0000878088-11-000047
2011-05-09 PAR Pharmaceutical Companies, Inc.
PRX
S, Open-market sale 1,500 disposed 35.12 52,680.00 Form 4, filing 0000878088-11-000047
2011-05-09 PAR Pharmaceutical Companies, Inc.
PRX
S, Open-market sale 1,300 disposed 34.55 44,915.00 Form 4, filing 0000878088-11-000047
2011-05-09 PAR Pharmaceutical Companies, Inc.
PRX
S, Open-market sale 700 disposed 34.50 24,150.00 Form 4, filing 0000878088-11-000047
2011-05-09 PAR Pharmaceutical Companies, Inc.
PRX
S, Open-market sale 600 disposed 35.10 21,060.00 Form 4, filing 0000878088-11-000047
2011-05-09 PAR Pharmaceutical Companies, Inc.
PRX
S, Open-market sale 400 disposed 34.48 13,792.00 Form 4, filing 0000878088-11-000047
2011-05-09 PAR Pharmaceutical Companies, Inc.
PRX
S, Open-market sale 353 disposed 35.25 12,443.25 Form 4, filing 0000878088-11-000047
2011-05-09 PAR Pharmaceutical Companies, Inc.
PRX
S, Open-market sale 300 disposed 35.11 10,533.00 Form 4, filing 0000878088-11-000047
2011-05-09 PAR Pharmaceutical Companies, Inc.
PRX
S, Open-market sale 300 disposed 34.56 10,368.00 Form 4, filing 0000878088-11-000047
2011-05-09 PAR Pharmaceutical Companies, Inc.
PRX
S, Open-market sale 200 disposed 35.22 7,045.00 Form 4, filing 0000878088-11-000047

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase

Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 9
  • Open-market sale 85
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. HAUGHEY THOMAS, insider transactions. Retrieved 2026-08-20 from https://ebomi.com/insider/0001272247

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.